De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed

被引：0
|
作者：
Juraj Stanik
Petra Dusatkova
Ondrej Cinek
Lucia Valentinova
Miroslava Huckova
Martina Skopkova
Lenka Dusatkova
Daniela Stanikova
Mikulas Pura
Iwar Klimes
Jan Lebl
Daniela Gasperikova
Stepanka Pruhova
机构：
[1] Slovak Academy of Sciences,DIABGENE Laboratory, Institute of Experimental Endocrinology
[2] Medical Faculty of Comenius University,First Department of Pediatrics
[3] Charles University in Prague and University Hospital Motol,Department of Pediatrics, 2nd Faculty of Medicine
[4] National Institute of Endocrinology and Diabetology,Centre for Molecular Medicine
[5] Slovak Academy of Sciences,undefined
来源：
Diabetologia | 2014年 / 57卷
关键词：
De novo mutations; Diabetes; MODY;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：480 / 484
页数：4
相关论文
共 50 条
  • [31] Intima - media thickness and endothelial dysfunction in GCK and HNF1A MODY patients
    Osmenda, G.
    Szopa, M.
    Wilk, G.
    Matejko, B.
    Solecka, I.
    Guzik, T.
    Malecki, M. T.
    DIABETOLOGIA, 2014, 57 : S155 - S156
  • [32] PSP/Reg and hsCRP Serum Levels May Discriminate HNF1A from HNF4A-MODY
    Kyithar, Ma P.
    Bacon, Siobhan
    Bonner, Caroline
    Schmid, Jasmin
    Graf, Rolf
    Prehn, Jochen H. M.
    Byrne, Maria M.
    DIABETES, 2011, 60 : A541 - A542
  • [33] Species-Specific Differences in the Expression of the HNF1A, HNF1B and HNF4A Genes
    Harries, Lorna W.
    Brown, James E.
    Gloyn, Anna L.
    PLOS ONE, 2009, 4 (11):
  • [34] ENDOTHELIAL DYSFUNCTION AND INTIMA-MEDIA THICKNESS IN GCK AND HNF1A MODY PATIENTS
    Szopa, M.
    Osmenda, G.
    Wilk, G.
    Matejko, B.
    Guzik, T.
    Malecki, M. T.
    ATHEROSCLEROSIS, 2014, 235 (02) : E245 - E245
  • [35] Evaluation in Monogenic Diabetes of the Impact of GCK, HNF1A, and HNF4A Variants on Splicing through the Combined Use of In Silico Tools and Minigene Assays
    Bouvet, Delphine
    Blondel, Amelie
    Agathe, Jean-Madeleine de Sainte
    Leroy, Gwendoline
    Saint-Martin, Cecile
    Bellanne-Chantelot, Christine
    HUMAN MUTATION, 2023, 2023
  • [36] The Story of a de novo Heterozygous HNF1A Mutation
    Ponmani, Caroline
    Banerjee, Kausik
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 239 - 239
  • [37] Molecular mechanism of HNF-1A-mediated HNF4A gene regulation and promoterdriven HNF4A-MODY diabetes
    Kind, Laura
    Molnes, Janne
    Tjora, Erling
    Raasakka, Arne
    Myllykoski, Matti
    Colclough, Kevin
    Saint-Martin, Cecile
    Adelfalk, Caroline
    Dusatkova, Petra
    Pruhova, Stepanka
    Valtonen-Andre, Camilla
    Bellanne-Chantelot, Christine
    Arnesen, Thomas
    Kursula, Petri
    Njolstad, Pal Rasmus
    JCI INSIGHT, 2024, 9 (11)
  • [38] A Comprehensive Analysis of Hungarian MODY Patients-Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in HNF1A, HNF1B, HNF4A, ABCC8 and INS Genes
    Gaal, Zsolt
    Szucs, Zsuzsanna
    Kantor, Iren
    Luczay, Andrea
    Toth-Heyn, Peter
    Benn, Orsolya
    Felszeghy, Eniko
    Karadi, Zsuzsanna
    Madar, Laszlo
    Balogh, Istvan
    LIFE-BASEL, 2021, 11 (08):
  • [39] Mutations in the Hepatocyte Nuclear Factor 1 Alpha (HNF1A), 4 Alpha (HNF4A) and 1 Beta (HNF1B) in Maturity-Onset Diabetes of the Young in Croatia
    Caban, D.
    Merkler, A.
    Ljubic, H.
    Uroic, A. Spehar
    Krnic, N.
    Naglic, M. Cavlovic
    Smircic-Duvnjak, L.
    Kastelan, D.
    Sertic, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1262 - 1262
  • [40] Variants in alternate coding regions of HNF1A and HNF1beta genes may be a rare cause of MODY
    Locke, J. M.
    Ellard, S.
    Hattersley, A. T.
    Colclough, K.
    Harries, L. W.
    DIABETIC MEDICINE, 2008, 25
12345